750 results on '"Ossendorp, Ferry"'
Search Results
2. Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer
3. Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment
4. T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
5. Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation
6. OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
7. Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer
8. The role of pigmentation in tumor treatment with the investigational virus-like drug conjugate belzupacap sarotalocan in an in vitro and in vivo murine model
9. A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
10. M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer
11. Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control
12. Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
13. Quantification of Lipid and Peptide Content in Antigenic Peptide-loaded Liposome Formulations by Reversed-phase UPLC using UV Absorbance and Evaporative Light Scattering Detection
14. Upconversion nanoparticle platform for efficient dendritic cell antigen delivery and simultaneous tracking
15. Measuring the Antitumor T-Cell Response in the Context of Photodynamic Therapy
16. Combination of Photodynamic Therapy and Immune Checkpoint Blockade
17. Combination of Photodynamic Therapy and Therapeutic Vaccination
18. Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma Model
19. Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies
20. Photodynamic cancer therapy enhances accumulation of nanoparticles in tumor-associated myeloid cells
21. Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses
22. Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses
23. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences
24. Dual‐Targeting Nanoliposome Improves Proinflammatory Immunomodulation of the Tumor Microenvironment.
25. Chapter Two - How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigens.
26. Dual‐Targeting Nanoliposome Improves Pro‐inflammatory Immunomodulation of the Tumor Microenvironment
27. Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells
28. In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity
29. Hollow microneedle-mediated micro-injections of a liposomal HPV E743–63 synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses
30. Autoreactive CD8 T Cells Associated with β Cell Destruction in Type 1 Diabetes
31. Data from CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy
32. Data from Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
33. Figure S1 from CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy
34. Supplementary Figure 2 from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
35. Supplementary Figure Legends from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
36. Data from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
37. Supplementary Tables 1 and 2 and Supplementary Figures 1 through 7 from Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
38. Figure legends from CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy
39. Supplementary Figure 1 from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
40. Supplementary Figure 2 from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
41. CCR Translation for This Article from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
42. Supplementary Figure Legend from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
43. Supplemental figure 3 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
44. Supplementary Figure 1 from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
45. Supplementary Figure 3 from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
46. Supplemental figure 4 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
47. Data from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
48. Supplemental Video 2 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
49. Supplemental figure 2 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
50. supplementary legend from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.